Abiopharma

Quoin Pharmaceuticals Receives FDA Conditional Approval of QYLEKI™ as the Proposed Brand Name for QRX003 for Netherton Syndrome

TOMI Reports Accelerating SteraMist Adoption as Ebola Outbreaks and Global Biosecurity Threats Drive Preparedness Spending

Ambiq Launches heliaCORE for Real-World Edge AI Deployment

IAA Announces New Market Alliance in El Salvador

Nexalin Technology Announces that the Investigator of Its Brazilian Clinical Trial Received the Young Researcher Award at BRAIN 2026 for Research Evaluating the Company’s Proprietary DIFS™ Platform

NewtekOne Automates Insurance Integration Within Its Proprietary Loan Operating System

The Elmet Group Co. Set to Join Russell 3000® and Russell Microcap® Indexes

NYC Suburbs and the Bay Area Are This Spring’s Most Competitive Housing Markets

DiaMedica Therapeutics Announces First Patients Dosed in Phase 2 Trial of DM199 for the Treatment of Fetal Growth Restriction

Quantum Computing Inc. Completes Acquisition of NHanced Semiconductors, Inc.